SCD is often promoted for people with inflammatory bowel diseases (IBD), but very few studies support its effectiveness. Over the last decade, the incidence of IBD has increased worldwide. Symptoms ...
81.7% of patients were on an SGLT2 inhibitor 74.7% of patients were on an ARNI 95.1% of patients were on a beta-blocker 83.1% of patients were on an MRA Despite high use of GDMT, the rate of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback